KRISTIN BUGG: Open Payments
NPI 1023657988 · HENDERSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 48 payments from 16 companies in 2025. Trend: 2023 $858 · 2024 $980 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $284 |
| AstraZeneca Pharmaceuticals LP | 3 | $176 |
| PFIZER INC. | 9 | $136 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Corium, LLC | 2 | $32 |
| Novo Nordisk Inc | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: UBRELVY, FARXIGA, ELIQUIS, VRAYLAR, PREVNAR 20, QULIPTA, REXULTI, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
